Collaboration to enhance Thermo Fisher Scientific’s COVID-19 diagnostic testing solution

American provider of scientific instruments, Thermo Fisher Scientific (MA, USA), has announced a collaboration with software automation provider, Artificial (CA, USA), to develop an automation platform for Thermo Fisher Scientific’s standardized COVID-19 testing platform. The Thermo Fisher Scientific Amplitude Solution is a highly automated molecular testing solution, able to analyze up to 8000 SARS-CoV-2 samples in 24 hours. Through their collaboration with Thermo Fisher Scientific, Artificial will provide access to its aLab Suite software and integrate it with the Thermo Scientific Momentum Workflow software. You may also be interested in: Potential COVID-19 biomarkers identified through mass spectrometry and machine-learning algorithms...